Industry opportunities are increasing for biosimilars, but companies should pay close attention to delivery device design to facilitate success.

Applied DNA Sciences said on Tuesday that it has partnered with Stony Brook University Hospital to validate the company's SARS-CoV-2 diagnostic.

Envisagenics announced Tuesday it has entered into a research program agreement with Johnson & Johnson's Lung Cancer Initiative (LCI.)

A group of life sciences and bioinformatics companies have banded together in the race to find treatments, vaccines, and a cure for COVID-19.

Austrian biopharma firm Viravaxx said on Tuesday that it is collaborating with the Medical University of Vienna to create a platform for diagnostic and vaccine research into COVID-19.

Exact Sciences reported on Tuesday after the close of the market that its preliminary first quarter revenues are expected to rise about 115 percent

South Korean molecular diagnostics firm Seegene announced after the close of the market on Tuesday that the US Food and Drug Administration has granted Emergency Use Authorization for the firm's Allplex 2019-nCoV Assay

A new study launched by scientists at Hannover Medical School (MHH) in Germany is determined to find out why patients respond differently to COVID-19.

Two months into the COVID-19 pandemic, the number of SARS-CoV-2 molecular diagnostic tests across the US remains woefully inadequate.

In the months since SARS-CoV-2 emerged and began spreading, researchers have been attempting to collect new data to understand the virus and COVID-19 disease it causes.

Genomic epidemiology papers from two independent teams are exploring potential sources of recent SARS-CoV-2 introductions to China's Guangdong province and to Connecticut, respectively

A new consortium spearheaded by the New York Genome Center aims to foster and organize genomic COVID-19 research in the New York metropolitan area.

A public-private consortium in Israel will collect samples and sequence genomes from thousands of COVID-19 patients in an effort to identify protective and risk-bearing genetic factors with the hopes of discovering new diagnostic and treatment methods.

This article has been updated from a previous version to include additional information about the saliva collection device specified in the EUA summary.

Lawmakers on Thursday called on the US Food and Drug Administration to provide information about the accuracy of the various SARS-CoV-2 diagnostics being used in response to the ongoing pandemic.